Skip to main content

Table 1 Summary of mutation detection.

From: A cancer derived mutation in the Retinoblastoma gene with a distinct defect for LXCXE dependent interactions

 

Blood samples

Tumor samples

   

Breast

Ovarian

 

Screened

Mutations

Screened

Mutations

Screened

Mutations

Exon 21

627

0

50

0

21

0

Exon 22

627

0

50

0

21

0

Exon 23

627

0

50

0

21

0

  1. To detect heterozygous sequence changes, peripheral blood samples from breast and/or ovarian cancer patients were subjected to HRM analysis using primers specific to exons 21, 22 and 23. To detect potentially homozygous sequence changes from breast and ovarian tumor samples, PCR amplicons of these exons were directly sequenced.